400,000 400,000
Current portion of real estate loan 33,000 33,000
------ ------
Total current liabilities 3,243,000 2,707,000
Long-term liabilities:
Notes Payable - T.I. Loan 1,267,000 1,367,000
Real estate loan 1,519,000 1,528,000
Deferred income taxes 173,000 171,000
Deferred rent 224,000 212,000
------- -------
Total long-term liabilities 3,183,000 3,278,000
Total liabilities 6,426,000 5,985,000
--------- ---------
Commitments and contingencies
Shareholders' equity:
Common shares; no par value;
50,000,000 shares authorized;
9,668,671 shares issued and
outstanding Sept 30, 2009
9,668,671 shares issued and
outstanding June 30, 2009 16,609,000 16,574,000
Accumulated deficit (5,909,000) (6,092,000)
---------- ----------
Total shareholders' equity 10,700,000 10,482,000
Total liabilities and
shareholders' equity $17,126,000 $16,467,000
=========== ===========
See notes to condensed consolidated financial statements.
PRO-DEX, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended September 30 (unaudited)
'/>"/>SOURCE Pro-Dex, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine technology :1.
Perrigo Company Announces Dividend Increase2.
Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast3.
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor4.
Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation5.
Grupo Casa Saba Announces 3Q09 Earnings Report6.
Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 20097.
BioMarin Announces Third Quarter 2009 Financial Results8.
Rigel Announces Presentations at Two Investor Conferences9.
Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast10.
STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call11.
CardioGenics Holdings Inc. Announces Letter to Shareholders